Altogether, the results showed YB1-provoked NK cells were larger, had greater cytotoxicity to tumor cells, and had higher expression levels of CD11b, CD11c, NKG2D, and CD38 compared to the NK cells from PBS-treated mice. The gene discussed is ITGAX; the disease is neoplasm.